December 11, 2007 - The FDA issued its final assessment of two long-term studies in patients with severe gastroesophageal reflux disease (GERD) who were being treated with either Prilosec or Nexium, and finds that “long-term use of these drugs is not likely to be associated with increased risk of heart problems.”

December 11, 2007 – Due to the loss of more than 50 percent of the North American Mo-99 supply and its impact on the ...

December 10, 2007 - Cardica Inc. announced that leading cardiac surgeons from The Heart Hospital Baylor Plano and ...

December 10, 2007 – Ymed Inc. announced that it has successfully completed its first U.S. cases with its proprietary ...

December 7, 2007 — GE Healthcare has licensed a technique patented by an Eastern Virginia Medical School (EVMS) ...

December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.

December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...

By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...